|
Status |
Public on Sep 19, 2016 |
Title |
prostate_cancer_primary_BCR_83 |
Sample type |
RNA |
|
|
Source name |
primary prostate cancer FFPE tissue sample, did not develop metastasis
|
Organism |
Homo sapiens |
Characteristics |
tissue: primary prostate cancer metastatic event: 0
|
Treatment protocol |
Not applicable.
|
Growth protocol |
Not applicable.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted from four 10 um FFPE sections. The highest Gleason grade was macrodissected from surrounding non-neoplastic cells, guided by an H&E stained slide for tumor identification. RNA was extracted and purified using the Roche HighPure FFPE kit.
|
Label |
biotin
|
Label protocol |
RNA was amplified, fragmented and biotinylated using the WT-Ovation FFPE system (NuGen, San Carlos, CA) according to the manufacturer's recommendations with minor modifications.
|
|
|
Hybridization protocol |
Samples were hybridized using Affymetrix hybridization kit materials and protocols.
|
Scan protocol |
Affymetrix GeneChIP Scanner 3000 7G.
|
Description |
GBX.VAL.PCA83 Samples are from men with biochemical recurrence (BCR) following radical prostatectomy (RP).
|
Data processing |
Data were processed using fRMA software package (Bioconductor). Probe group file: HuEx-1_0-st-v1.r2.pgf Meta-probeset file: Not applicable.
|
|
|
Submission date |
Sep 20, 2013 |
Last update date |
Sep 19, 2016 |
Contact name |
Elai Davicioni |
E-mail(s) |
[email protected]
|
Organization name |
Veracyte, Inc
|
Street address |
9725 Lusk Blvd
|
City |
San Diego |
State/province |
California |
ZIP/Postal code |
92121 |
Country |
USA |
|
|
Platform ID |
GPL5188 |
Series (1) |
GSE51066 |
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy |
|